vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and QUINSTREET, INC (QNST). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $287.8M, roughly 1.7× QUINSTREET, INC). QUINSTREET, INC runs the higher net margin — 17.4% vs -10.1%, a 27.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 1.9%). QUINSTREET, INC produced more free cash flow last quarter ($20.7M vs $-69.0M). Over the past eight quarters, QUINSTREET, INC's revenue compounded faster (53.2% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

QuinStreet, Inc. is a publicly traded online marketing company based in Foster City, California. The company helps generate web traffic for clients by acquiring popular domain names.

CLOV vs QNST — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.7× larger
CLOV
$487.7M
$287.8M
QNST
Growing faster (revenue YoY)
CLOV
CLOV
+42.9% gap
CLOV
44.7%
1.9%
QNST
Higher net margin
QNST
QNST
27.6% more per $
QNST
17.4%
-10.1%
CLOV
More free cash flow
QNST
QNST
$89.7M more FCF
QNST
$20.7M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
QNST
QNST
Annualised
QNST
53.2%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CLOV
CLOV
QNST
QNST
Revenue
$487.7M
$287.8M
Net Profit
$-49.3M
$50.2M
Gross Margin
9.6%
Operating Margin
-10.1%
0.4%
Net Margin
-10.1%
17.4%
Revenue YoY
44.7%
1.9%
Net Profit YoY
-123.2%
3342.5%
EPS (diluted)
$0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
QNST
QNST
Q4 25
$487.7M
$287.8M
Q3 25
$496.6M
$285.9M
Q2 25
$477.6M
Q1 25
$462.3M
$269.8M
Q4 24
$337.0M
$282.6M
Q3 24
$331.0M
$279.2M
Q2 24
$356.3M
$198.3M
Q1 24
$346.9M
$168.6M
Net Profit
CLOV
CLOV
QNST
QNST
Q4 25
$-49.3M
$50.2M
Q3 25
$-24.4M
$4.5M
Q2 25
$-10.6M
Q1 25
$-1.3M
$4.4M
Q4 24
$-22.1M
$-1.5M
Q3 24
$-9.2M
$-1.4M
Q2 24
$7.4M
$-2.2M
Q1 24
$-19.2M
$-7.0M
Gross Margin
CLOV
CLOV
QNST
QNST
Q4 25
9.6%
Q3 25
9.4%
Q2 25
Q1 25
10.3%
Q4 24
9.5%
Q3 24
24.5%
10.2%
Q2 24
30.3%
8.8%
Q1 24
23.6%
8.5%
Operating Margin
CLOV
CLOV
QNST
QNST
Q4 25
-10.1%
0.4%
Q3 25
-4.9%
1.7%
Q2 25
-2.2%
Q1 25
-0.3%
1.8%
Q4 24
-6.4%
-0.5%
Q3 24
-2.7%
-0.4%
Q2 24
2.0%
-0.7%
Q1 24
-6.5%
-3.2%
Net Margin
CLOV
CLOV
QNST
QNST
Q4 25
-10.1%
17.4%
Q3 25
-4.9%
1.6%
Q2 25
-2.2%
Q1 25
-0.3%
1.6%
Q4 24
-6.6%
-0.5%
Q3 24
-2.8%
-0.5%
Q2 24
2.1%
-1.1%
Q1 24
-5.5%
-4.2%
EPS (diluted)
CLOV
CLOV
QNST
QNST
Q4 25
$0.87
Q3 25
$0.08
Q2 25
Q1 25
$0.08
Q4 24
$-0.03
Q3 24
$-0.02
Q2 24
$-0.04
Q1 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
QNST
QNST
Cash + ST InvestmentsLiquidity on hand
$78.3M
$107.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$294.4M
Total Assets
$541.0M
$493.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
QNST
QNST
Q4 25
$78.3M
$107.0M
Q3 25
$101.3M
Q2 25
Q1 25
$81.8M
Q4 24
$194.5M
$57.8M
Q3 24
$288.0M
$25.0M
Q2 24
$254.8M
$50.5M
Q1 24
$208.3M
$39.6M
Stockholders' Equity
CLOV
CLOV
QNST
QNST
Q4 25
$308.7M
$294.4M
Q3 25
$340.9M
$246.7M
Q2 25
$344.2M
Q1 25
$336.1M
$235.5M
Q4 24
$341.1M
$224.3M
Q3 24
$342.2M
$219.8M
Q2 24
$324.9M
$216.8M
Q1 24
$292.5M
$215.0M
Total Assets
CLOV
CLOV
QNST
QNST
Q4 25
$541.0M
$493.0M
Q3 25
$559.7M
$442.6M
Q2 25
$575.0M
Q1 25
$583.7M
$417.2M
Q4 24
$580.7M
$409.6M
Q3 24
$653.0M
$401.2M
Q2 24
$674.2M
$368.5M
Q1 24
$671.8M
$349.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
QNST
QNST
Operating Cash FlowLast quarter
$-66.9M
$21.6M
Free Cash FlowOCF − Capex
$-69.0M
$20.7M
FCF MarginFCF / Revenue
-14.1%
7.2%
Capex IntensityCapex / Revenue
0.4%
0.3%
Cash ConversionOCF / Net Profit
0.43×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$106.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
QNST
QNST
Q4 25
$-66.9M
$21.6M
Q3 25
$12.1M
$19.6M
Q2 25
$5.4M
Q1 25
$-16.3M
$30.1M
Q4 24
$34.8M
$38.7M
Q3 24
$50.0M
$-13.7M
Q2 24
$44.8M
$16.6M
Q1 24
$25.9M
$4.1M
Free Cash Flow
CLOV
CLOV
QNST
QNST
Q4 25
$-69.0M
$20.7M
Q3 25
$11.4M
$18.4M
Q2 25
$4.8M
Q1 25
$-16.5M
$29.5M
Q4 24
$33.3M
$38.2M
Q3 24
$49.6M
$-14.1M
Q2 24
$44.4M
$15.4M
Q1 24
$25.5M
$2.9M
FCF Margin
CLOV
CLOV
QNST
QNST
Q4 25
-14.1%
7.2%
Q3 25
2.3%
6.4%
Q2 25
1.0%
Q1 25
-3.6%
10.9%
Q4 24
9.9%
13.5%
Q3 24
15.0%
-5.1%
Q2 24
12.5%
7.8%
Q1 24
7.3%
1.7%
Capex Intensity
CLOV
CLOV
QNST
QNST
Q4 25
0.4%
0.3%
Q3 25
0.1%
0.4%
Q2 25
0.1%
Q1 25
0.0%
0.2%
Q4 24
0.5%
0.2%
Q3 24
0.1%
0.2%
Q2 24
0.1%
0.6%
Q1 24
0.1%
0.7%
Cash Conversion
CLOV
CLOV
QNST
QNST
Q4 25
0.43×
Q3 25
4.32×
Q2 25
Q1 25
6.82×
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

QNST
QNST

Financial Service$216.8M75%
Home Services And Other Revenue$71.0M25%

Related Comparisons